CS Paper Radar

Dissecting Neuro-Symbolic Quality Assurance for Synthetic Oncology Data Generation

Laxmigayathri Challa, Yuhan Zhou, Ana Cleveland, Haihua Chen

cs.AI ·submitted 2026-08-22 19:34 UTC · v1

Abstract

Synthetic clinical data generation with large language models addresses the scarcity that limits cancer staging research, but oncology hallucinations are categorically harmful: one clinically impossible staging assignment contaminates every downstream model trained on it. Neuro-symbolic pipelines validate during generation, yet the contribution of individual quality-assurance components remains unclear. We report three controlled studies isolating gate necessity, constraint attribution, and retrieval conditionality, holding generation protocol, diversity thresholds, and fine-tuning hyperparameters constant across adapter conditions. The symbolic gate enforces schema completeness, ontology coverage against the Systematized Nomenclature of Medicine, and staging-logic consistency under American Joint Committee on Cancer eighth-edition rules. Ungated, 29.9% of records contain schema failures and 20.1% contain clinically invalid staging. Schema validation is the load-bearing filter: within the fully gated corpus it rejects 148 of 512 records, ontology grounding a further 24, and staging-logic validation none---the only generator producing logic violations is already excluded on schema, making clinical-logic validation a generator-conditional safeguard rather than the dominant filter. Retrieval augmentation is strongly model-dependent: it improves gate compliance for one generator by 12.5 percentage points, has no measurable effect for a second, and collapses output in a third. Across gated configurations ontology density is largely unchanged, indicating that symbolic validation improves clinical validity rather than vocabulary richness. Symbolic gating therefore buys corpus validity but no commensurate gain on real lung-cancer notes in this study; retrieval should be evaluated per model, and ontology density should not be reported as a proxy for corpus quality.

Comment
14 pages, 7 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation

cs.AI cs.CL ·2026-08-31 ·Bahar İlgen, Yiannos Tolias, Denise Kühnert, Paraskevi Papadopoulou, Magnus Westerlund +3 more
similarity 0.67
Abstract · Review article

Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring.

0.12

OpenMTB-Audit: Exposing Over-Refusal and Clinical Expert Perspectives in LLM-Based Molecular Tumor Board Safety Evaluation

cs.AI cs.LG ·2026-10-01 ·Negin Ashrafi, Jia Luo, Stacey M. Frumm, Roxana Daneshjou
publishedbenchmarkcode/data similarity 0.65
Abstract · Accepted for oral presentation and publication at the Pacific Symposium on Biocomputing (PSB) 2027

Molecular tumor boards integrate genomic findings, clinical context, and therapeutic evidence to support precision oncology. As AI enters this workflow, a key safety challenge is distinguishing truly unsupported recommendations from evidence-supported options that still require oncologist review because of incomplete information, poor ECOG performance status, or other clinical caveats. We introduce OpenMTB-Audit, an open-source benchmark of 500 synthetic non-small cell lung cancer cases spanning five adversarial error categories and four safety labels: Supported, Partially Supported, Unsupported, and Insufficient Information. Across eight large language model configurations, we identify pervasive over-refusal: all LLM configurations failed to retain the Partially Supported label in 83.3-100% of true Partially Supported cases, achieving high aggregate safety scores through label collapse rather than clinically calibrated reasoning. To address this limitation, we developed MTB-AuditAgent, a deterministic seven-module framework separating evidence verification, missing-information detection, safety classification, and abstention. It reduces over-refusal to 6.7% and achieves 91.2% accuracy (95% CI: 88.6-93.6%). A two-oncologist annotation study found disagreement concentrated at the boundary between information sufficiency and treatment optimization, underscoring the need to preserve clinically meaningful distinctions.

0.57

NSIDDx: A Design Framework for Neuro-Symbolic, Practitioner-First Differential Diagnosis in Low-Resource Settings

cs.CL ·2026-08-31 ·Aarav Singh
code/data similarity 0.63
Abstract · 13 pages, 2 figures, Github: https://github.com/joetheguide2/NSIDDX-

LLM-based diagnostic systems achieve high semantic accuracy on benchmarks, but open-ended evaluation on clinically uncommon presentations reveals a systematic gap between headline accuracy and verifiable clinical reliability. We evaluate an LLM+rare-disease-RAG pipeline across two cohorts and show that the paradigm produces confident outputs that are frequently unverifiable and systematically resistant to clinician interrogation. We present NSIDDx (Neuro-Symbolic Integrated Differential Diagnosis System), a design framework arguing that DDx systems in low-resource settings must treat the clinician as an active reasoning agent. We instantiate this through a neuro-symbolic pipeline with ternary symptom encoding, contradiction detection, audit strings, and practitioner override - running offline on consumer hardware. We distill five design principles for clinician-in-the-loop clinical NLP and invite the prospective studies needed to validate the claim at scale.

0.40

Review Before Trust: Source-Grounded Integrity Gates for AI-Assisted Personal Health Records

cs.AI ·2026-08-30 ·Nora Girda, Adrian Groza
similarity 0.61
Abstract

Large language models can convert medical documents into structured data, but plausible output may still be unsupported by the source. Persisting such output in a longitudinal health record, a record that accumulates patient information over time, therefore creates an integrity risk: unverified data may influence later summaries, trends, or preventive-care computations. We introduce an evidence-gated trust-promotion model that keeps generated data provisional until a deterministic monitor verifies it against the source document. The monitor admits a candidate for a specified downstream use only when the source contains a unique supporting quotation, the relevant fields occur within the same laboratory row, and the required provenance is preserved. The generator cannot approve its own output, missing or ambiguous evidence causes refusal, and refused candidates remain available for human review rather than being silently discarded. We implement the model in Medical DataCloud, a personal health-record application, and evaluate it through automated tests and a replay of saved extraction outputs. All 22 conformance and mutation tests pass. The replay covers nine historical laboratory PDF reports containing 102 manually labelled rows. The reports produce 97 numeric candidates: schema validation accepts all 97, an earlier packet-level evidence check accepts 94, and the hardened quotation- and row-level policy admits 72 while retaining 25 for review. The study evaluates system integrity rather than clinical correctness or clinical safety. The results demonstrate the technical feasibility of an enforceable boundary that prevents generated claims from authorizing their own reuse in a longitudinal health record.

0.21

From Fluent Text to Ontology-Compatible Definitions: A Quality-Control Agentic Workflow

cs.AI ·2026-11-09 ·Kun Feng, Chenchen Chu, Yan Liu, Haojie Sun, Jijun Tang +4 more
similarity 0.61
Abstract

Biomedical ontologies are structured knowledge systems that must evolve continuously to represent newly emerging knowledge, but their manual maintenance remains time-consuming and laborintensive. Textual definitions are especially costly because they must be readable to humans and compatible with controlled entities, relations, and logical constraints. Large language models (LLMs) offer a promising way to assist ontology engineering tasks, including definition generation. However, textual plausibility does not guarantee knowledge-system compatibility. A generated definition may be fluent and close to a reference definition, yet still fail to ground its implied entities or violate ontology-level constraints. Directly inserting such definitions into ontology libraries may therefore introduce entity-level hallucinations and logical inconsistencies. To address this problem, we propose two structured-knowledge incompatibility metrics, Entity Error Rate (EER) and Logical Inconsistency Rate (LIR), to quantify entity grounding and logical consistency for LLM-generated ontology definitions. We further develop an agentic quality-control (QC) workflow that treats definition generation as an iterative process rather than a direct decoding step: it generates definitions, extracts axioms, checks entity existence and logical consistency, and uses the resulting diagnostics to drive repair loops. Comprehensive experiments on Disease Ontology, Uberon Ontology, and Uberon-ConstraintStress demonstrate that EER and LIR complement conventional reference-based metrics by evaluating whether generated content can be grounded and checked inside the target ontology. The workflow effectively decreases EER while maintaining strong conventional text-generation performance. LIR further exposes sparse ontology-level logical failures that are invisible to text similarity metrics, although their repair remains limited.

0.22

Evidence-Bound Reasoning: Neuro-Semantic Verification of Biomedical AI in Glioblastoma Radiogenomics

cs.CL ·2026-10-06 ·Mariya Miteva, Maria Nisheva-Pavlova
benchmark similarity 0.61
Abstract · 15 pages, 4 figures, 4 tables. Preprint

Background: Biomedical AI can generate plausible explanations without reliably verifying whether each statement is supported by patient-specific evidence. We developed a neuro-semantic verification framework that converts radiomic measurements into addressable evidence records and machine-checkable claims. Methods: UPenn-GBM radiomics were aligned with de novo CaPTk extraction from standardized MRI and expert-validated segmentations in an independent multicenter cohort. The shared space comprised 1,728 features from T1, T1GD, T2, and FLAIR MRI across three tumor regions. Reference-defined semantic states were derived from 611 UPenn cases. We evaluated cross-cohort transportability, model-linked provenance, deterministic verification, controlled predictive degradation, and an LLM claim-extraction pilot; MGMT prediction served only as a transport stress test. Results: Median semantic-state agreement was 0.786 (weighted kappa 0.709), ranging from 0.918 for morphologic to 0.252 for intensity features. The external evidence ledger contained 1,655 model-linked records for 331 patients. The verifier achieved 100% exact-set accuracy in a 6,620-claim corruption benchmark. In a 24-case pilot, GPT-5.6 Sol reproduced 72/72 prespecified atomic claims, and the frozen verifier recovered 24/24 expected conditions. During controlled degradation, ROC AUC declined from 0.899 to 0.500 while verification accuracy remained 1.000. External MGMT discrimination was weak (ROC AUC 0.543). Conclusions: Verifiability can be engineered and evaluated independently of predictive performance. LLMs may structure explanations, while final evidence-consistency checking remains deterministic.

0.23

A Semantic Model of Genetic Evidence: A Step Toward Bridging the Basic-Science-Clinic Gap

cs.DB cs.AIq-bio.GN ·2026-09-03 ·Michael Bouzinier, Dmitry Etin
benchmarkpositioncode/data similarity 0.61
Abstract · 16 pages; supplementary material (32 pages) included in this submission. Schema, annotations, and code: https://github.com/ForomePlatform/ge…

Scientific and clinical decision-making depends on evidence from the primary literature, but existing standards for representing that evidence (FHIR Evidence, ECO, SEPIO, and the GA4GH Genomic Knowledge Standards) are oriented toward clinical-trial workflows, evidence codes, or single-variant assertions, and do not capture the fine-grained, domain-specific structure of claims in basic and pre-clinical research. We introduce a semantic model for scientific evidence with three core classes, specialize it for genetics, align it structurally to FHIR Evidence with a SEPIO-anchored credibility decomposition, and attach a compact dimensional vocabulary whose conditional-activation rules are validated by a SHACL schema for the implemented constraints. Using clinical variant interpretation as the driving use case, we evaluate the model through a human-AI annotation pilot over six genetics papers, yielding 28 evidence items and 95 source-anchored assertions, with a workflow that keeps curator-authored reference annotations distinct from AI-drafted annotations. Treating the pilot as a feasibility study rather than a benchmark, we argue that the model is a useful increment toward trustworthy, AI-ready infrastructure for variant interpretation: a reference data model and validation schema for representing genetic evidence.

0.31

Formalizing Patient-Set Semantics for OMOP CDM-Based Clinical Trial Feasibility Assessment:A Neuro-Symbolic Methodology for Traceable Site-Feasibility Patient Counts

cs.IR ·2026-11-07 ·Sohyeon Jeon
similarity 0.59
Abstract

This study examines the interpretation and execution of natural-language eligibility criteria for clinical trial site-feasibility patient-count estimation using the OMOP Common Data Model (CDM). It treats each count as the size of a patient set produced under explicitly declared choices about clinical concepts, temporal conditions, exclusions, proxies, and available data. The study presents NS-CoT, a neuro-symbolic pipeline that uses an LLM to interpret and structure criteria, followed by symbolic processing and deterministic SQL compilation. Intermediate representations and execution records document how criteria are translated into patient sets and counts. Evaluation uses synthetic OMOP CDM data, controlled benchmarks, and a multi-site simulation. Comparisons with a direct-SQL baseline examine execution success, count agreement, patient-set agreement, and preservation of reference-defined site-feasibility labels and rankings. Performance varies across evaluation settings. Layer-wise inspection also supports the identification of implementation and policy errors, followed by correction and re-evaluation. The work investigates the reviewability and fidelity of cohort computation relative to declared reference definitions. It does not establish that these definitions capture a unique clinical ground truth or demonstrate improved recruitment, site selection, or trial outcomes in practice.

0.28